Loading...

Clinical Research Progress of Immune Checkpoint Inhibitors in the Treatment of 
Small Cell Lung Cancer

With the in-depth study of tumor immunity, immunotherapy represented by immune checkpoint inhibitors has made a great breakthrough in solid tumors. Small cell lung cancer (SCLC) accounts for about 15%-20% of all lung cancers, with high malignancy, early metastasis and lack of effective treatment str...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Main Authors: Benlin HUANG, Yong DUAN
Format: Artigo
Sprog:Chinês
Udgivet: Chinese Anti-Cancer Association; Chinese Antituberculosis Association 2019-04-01
Serier:Chinese Journal of Lung Cancer
Fag:
Online adgang:http://dx.doi.org/10.3779/j.issn.1009-3419.2019.04.07
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!